Related Experiment Videos
Tentative interpretive criteria for the diffusion susceptibility test using 30-microgram netilmicin disks
Antimicrobial Agents and Chemotherapy
|September 1, 1980
Summary
The 30-microgram netilmicin disk diffusion test is recommended for clinical susceptibility testing. This method accurately predicts bacterial susceptibility to netilmicin, with specific zone size breakpoints for reliable interpretation.
Area of Science:
- Medical Microbiology
- Antimicrobial Susceptibility Testing
Background:
- Accurate antimicrobial susceptibility testing (AST) is crucial for guiding effective treatment decisions.
- Netilmicin is an aminoglycoside antibiotic used to treat serious bacterial infections.
Purpose of the Study:
- To correlate disk diffusion zone diameters with minimum inhibitory concentrations (MICs) for netilmicin.
- To establish optimal breakpoints for the 30-microgram netilmicin disk diffusion test.
Main Methods:
- Disk diffusion assay using 10-microgram and 30-microgram netilmicin disks.
- Testing against 471 clinical bacterial isolates in cation-supplemented Mueller-Hinton broth.
- Regression line and error-rate bounded analysis for breakpoint determination.
Main Results:
- The 30-microgram netilmicin disk demonstrated better correlation with MICs compared to the 10-microgram disk.
- Recommended breakpoints: >= 17 mm for susceptibility (<= 8 µg/ml) and <= 13 mm for resistance (> 32 µg/ml).
- Potential for minor interpretive errors with Pseudomonas strains having intermediate MICs (16 µg/ml).
Conclusions:
- The 30-microgram netilmicin disk diffusion test is a reliable method for clinical AST.
- Established breakpoints provide a basis for accurate interpretation of netilmicin susceptibility.
- Awareness of potential errors in intermediate ranges, particularly for Pseudomonas, is important.